🔥🐔 BizChicken 🐔🔥

Companies Similar to Arcus Biosciences, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. logo
Market Cap: Medium
Employees: Low

ARQ-151

Arcutis Biotherapeutics, Inc. is a biopharmaceutical company developing and commercializing treatments for dermatological diseases, including plaque psoriasis, atopic dermatitis, seborrheic dermatitis, scalp psoriasis, hand eczema, vitiligo, and alopecia areata.

Tags: alopecia areata, atopic dermatitis, biopharmaceutical, dermatological diseases, hand eczema, plaque psoriasis, scalp psoriasis, seborrheic dermatitis, vitiligo

Symbol: ARQT

Recent Price: $14.20

Industry: Biotechnology

CEO: Mr. Todd Franklin Watanabe M.A.

Sector: Healthcare

Employees: 296

Address: 3027 Townsgate Road, Westlake Village, CA 91361

Phone: 805 418 5006

Last updated: 2024-12-31

Candel Therapeutics, Inc.

Candel Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

CAN-2409, CAN-3110

Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.

Tags: biopharmaceutical, cancer treatment, clinical trials, immunotherapies

Symbol: CADL

Recent Price: $7.95

Industry: Biotechnology

CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.

Sector: Healthcare

Employees: 42

Address: 117 Kendrick Street, Needham, MA 02494

Phone: 617 916 5445

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

Arcellx, Inc.

Arcellx, Inc. logo
Market Cap: High
Employees: Low

CART-dd BCMA

Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.

Tags: acute myeloid leukemia, biotechnology, cancer treatment, clinical-stage, immunotherapy, multiple myeloma, myelodysplastic syndrome

Symbol: ACLX

Recent Price: $78.35

Industry: Biotechnology

CEO: Mr. Rami Elghandour

Sector: Healthcare

Employees: 130

Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878

Phone: 240 327 0603

Last updated: 2024-12-31

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

Zunsemetinib

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune-inflammatory diseases. It operates through Therapeutics and Contract Research segments, addressing unmet needs with innovative therapies, including treatments for rheumatoid and psoriatic arthritis, atopic dermatitis, autoimmune diseases, inflammatory bowel disease, and certain cancers.

Tags: atopic dermatitis, autoimmune diseases, biopharmaceutical, cancer, contract research, drug development, immune-inflammatory diseases, psoriatic arthritis, rheumatoid arthritis, therapeutics

Symbol: ACRS

Recent Price: $2.48

Industry: Medical - Diagnostics & Research

CEO: Dr. Neal S. Walker D.O., M.D.

Sector: Healthcare

Employees: 86

Address: 640 Lee Road, Wayne, PA 19087

Phone: 484 324 7933

Last updated: 2024-12-31

Agenus Inc.

Agenus Inc. logo
Market Cap: Low
Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

UCART19

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.

Tags: CAR T cell, allogeneic T cell therapies, cancer treatment, clinical trials, immuno-oncology

Symbol: ALLO

Recent Price: $2.10

Industry: Biotechnology

CEO: Dr. David D. Chang M.D., Ph.D.

Sector: Healthcare

Employees: 232

Address: 210 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 457 2700

Last updated: 2024-12-31

Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

AR-301

Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing targeted immunotherapies using fully human monoclonal antibodies to treat life-threatening infections.

Tags: S. aureus, biopharmaceutical, immunotherapy, lung infections, monoclonal antibodies

Symbol: ARDS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Vu L. Truong Ph.D.

Sector: Healthcare

Employees: 37

Address: 983 University Avenue, Los Gatos, CA 95032

Phone: 408 385 1742

Last updated: 2024-12-31

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

T-cell immunotherapy treatments

Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.

Tags: Autoimmune Diseases, Biotherapeutics, Cancer Treatment, Immunotherapy, T-Cell Therapy, Viral Diseases

Symbol: ATRA

Recent Price: $13.28

Industry: Biotechnology

CEO: Dr. Anhco Nguyen Ph.D.

Sector: Healthcare

Employees: 165

Address: 611 Gateway Boulevard, South San Francisco, CA 94080

Phone: 650 278 8930

Last updated: 2024-12-31

Aura Biosciences, Inc.

Aura Biosciences, Inc. logo
Market Cap: Medium
Employees: Low

AU-011

Aura Biosciences, Inc. operates as a biotechnology company developing virus-like drug conjugates (VDC) platform for treating ocular and urologic oncology tumors, with a focus on AU-011 for choroidal melanoma.

Tags: VDC technology, biotechnology, cancer therapy, choroidal melanoma, ocular oncology, oncology

Symbol: AURA

Recent Price: $8.13

Industry: Biotechnology

CEO: Dr. Elisabet de los Pinos Ph.D.

Sector: Healthcare

Employees: 88

Address: 85 Bolton Street, Cambridge, MA 02140

Phone: 617 500 8864

Leadership

  • David Johnson, Chairman
  • Elisabet de los Pinos, PhD, Chief Executive Officer
  • Giovanni Mariggi, PhD, Director
  • Antony Mattessich, Director
  • Sapna Srivastava, PhD, Director
  • Karan Takhar, Director

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Coherus BioSciences, Inc.

Coherus BioSciences, Inc. logo
Market Cap: Low
Employees: Low

UDENYCA

Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.

Tags: Toripalimab, UDENYCA, biopharmaceutical, biosimilars, immuno-oncology

Symbol: CHRS

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Dennis M. Lanfear

Sector: Healthcare

Employees: 306

Address: 333 Twin Dolphin Drive, Redwood City, CA 94065

Phone: 650 649 3530

Last updated: 2024-12-31

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. logo
Market Cap: Low
Employees: Lowest

CLR 131

Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.

Tags: biopharmaceutical, cancer treatment, drug development, phospholipid drug conjugate

Symbol: CLRB

Recent Price: $0.29

Industry: Biotechnology

CEO: Mr. James V. Caruso

Sector: Healthcare

Employees: 20

Address: 100 Campus Drive, Florham Park, NJ 07932

Phone: 608 441 8120

Leadership

  • James Caruso, President, CEO and Director
  • Chad Kolean, Chief Financial Officer
  • Shane Lea, Chief Commercial Officer
  • Jarrod Longcor, Chief Operating Officer
  • Andrei Shustov, Senior Vice President, Medical
  • Douglas J. Swirsky, Chairman of the Board
  • Asher Alban Chanan-Khan, MD., Director
  • Frederick W. Driscoll, Director
  • Stefan D. Loren, Ph.D., Director
  • John Neis, Director
  • Cellectar Biosciences, Inc., Company Information

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

Precision BioSciences, Inc.

Precision BioSciences, Inc. logo
Market Cap: Lowest
Employees: Low

ARCUS

Precision Bio Sciences, Inc. is a clinical stage gene editing company specializing in in vivo gene editing and ex vivo allogeneic CAR T therapies, including the ARCUS genome editing platform and various investigational CAR T immunotherapies.

Tags: CAR T therapies, allogeneic CAR T, clinical stage, gene editing, genetic disorders, immunotherapy

Symbol: DTIL

Recent Price: $4.26

Industry: Biotechnology

CEO: Mr. Michael Amoroso

Sector: Healthcare

Employees: 109

Address: 302 East Pettigrew Street, Durham, NC 27701

Phone: 919 314 5512

Last updated: 2024-12-31

Erasca, Inc.

Erasca, Inc. logo
Market Cap: Medium
Employees: Low

ERAS-007, ERAS-601, ERAS-801

Erasca, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Tags: ERAS-007, ERAS-601, ERAS-801, RAS/MAPK, biopharmaceutical, cancers

Symbol: ERAS

Recent Price: $2.55

Industry: Biotechnology

CEO: Dr. Jonathan E. Lim M.D.

Sector: Healthcare

Employees: 126

Address: 10835 Road to the Cure, San Diego, CA 92121

Phone: 858 465 6511

Last updated: 2024-12-31

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. logo
Market Cap: High
Employees: Low

NX-2127, NX-5948, NX-1607, NX-0255

Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.

Tags: BTK degrader, CBL-B inhibitor, biopharmaceutical, cancer, clinical trials, immune disorders

Symbol: NRIX

Recent Price: $18.64

Industry: Biotechnology

CEO: Dr. Arthur T. Sands M.D., Ph.D.

Sector: Healthcare

Employees: 284

Address: 1700 Owens Street, San Francisco, CA 94158

Phone: 415 660 5320

Last updated: 2024-12-31

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

therapeutics for cancer

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.

Tags: TJ004309, TRC102, YH001, biopharmaceutical, cancer therapeutics, clinical trials, envafolimab

Symbol: TCON

Recent Price: $0.03

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 17

Address: 4350 La Jolla Village Drive, San Diego, CA 92122

Phone: 858 550 0780

Last updated: 2024-12-31

Arcus Biosciences, Inc.

Arcus Biosciences, Inc. logo
Market Cap: High
Employees: Medium

Cancer Therapies

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.

Tags: biopharmaceutical, cancer therapies, clinical trials, oncology

Symbol: RCUS

Recent Price: $14.91

Industry: Biotechnology

CEO: Dr. Terry J. Rosen Ph.D.

Sector: Healthcare

Employees: 577

Address: 3928 Point Eden Way, Hayward, CA 94545

Phone: 510 694 6200

Last updated: 2024-12-31

Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc. logo
Market Cap: Medium
Employees: Low

RNA medicines

Arcturus Therapeutics Holdings Inc. focuses on developing vaccines for infectious and rare diseases, including programs for cystic fibrosis and ornithine transcarbamylase deficiency. The company collaborates with various partners for vaccine and therapeutic development.

Tags: RNA medicines, collaborations, infectious diseases, rare diseases, vaccines

Symbol: ARCT

Recent Price: $16.58

Industry: Biotechnology

CEO: Mr. Joseph E. Payne M.Sc.

Sector: Healthcare

Employees: 180

Address: 10628 Science Center Drive, San Diego, CA 92121

Phone: 858 900 2660

Last updated: 2024-12-31